Recs

0

The Razor Wars Continue

Gillette's (NYSE: G  ) campaign to put rival Energizer Holdings' (NYSE: ENR  ) razor business, Schick, to the sword is not going smoothly. In the latest round of legal disputes, Schick is suing Gillette for infringing on three of its razorblade patents. Last week's legal filing comes only a month after Gillette lost its own patent injunction against Schick.

The lawsuits are not mere publicity stunts. No, instead they offer a glimpse into the kind of warfare tactics that Gillette will face in the coming year.

The stakes are high. While Gillette controls 70% of the U.S. market, Schick has been nipping at Gillette's heels since drug giant Pfizer (NYSE: PFE  ) sold it (Schick) to Energizer Holdings last year for $930 million. The four-blade Schick Quattro has been the No.1 selling razor since its launch in the fall. This comes at the same time that Gillette is fighting another battle with Energizer to defend the market share of its Duracell battery business.

Shaving, unlike batteries, is not a commodity business. Gillette can look back on a successful history of innovation and marketing. Schick, though, has been an underperforming brand in the past.

Under Energizer Holdings' ownership, Schick will have to keep delivering a competitive punch. Having paid top dollar to buy it, Energizer needs to be aggressive here. And Gillette will have to respond in kind. In fact, because of the Quattro, Gillette will be pushing upgraded products into the market this year.

Higher marketing spending, combined with eroded market share, could reduce Gillette's earnings by 4% in 2004. That's certainly not the end of the world. But pinned down by a rejuvenated Energizer and forced to resort to down-and-dirty legal and competitive tactics, Gillette will have a tougher time maintaining its premium sector rating.

Motley Fool contributor Ben McClure spots stocks from the Great White North. He doesn't own any shares of the companies mentioned here.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 505699, ~/Articles/ArticleHandler.aspx, 2/13/2012 11:13:20 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 57 minutes ago Sponsored by:
DOW 12,874.04 72.81 0.57%
S&P 500 1,351.77 9.13 0.68%
NASD 2,931.39 27.51 0.95%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/13/2012 4:00 PM
PFE $21.30 Up +0.25 +1.19%
Pfizer, Inc. CAPS Rating: ****
ENR $76.40 Up +0.27 +0.35%
Energizer Holdings CAPS Rating: ****

Advertisement